Related Experiment Video
Updated: Jul 18, 2026
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Variation in ACE activity affects myogenic differentiation in C2C12 cells
Shuuichi Mori1, Kumpei Tokuyama
1Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8574, Japan.
Biochemical and Biophysical Research Communications
|December 26, 2006
Summary
Angiotensin-converting enzyme (ACE) negatively regulates skeletal muscle growth. Inhibiting ACE or blocking the AT2 receptor promotes muscle cell differentiation, while ACE overexpression hinders it.
Area of Science:
- Molecular Biology
- Muscle Physiology
- Biochemistry
Background:
- Angiotensin-converting enzyme (ACE) activity influences skeletal muscle function.
- The precise mechanisms by which ACE impacts muscle development are not fully understood.
Purpose of the Study:
- To investigate the role of ACE activity in myogenic differentiation.
- To elucidate the signaling pathways involved in ACE-mediated regulation of skeletal muscle formation.
Main Methods:
- Utilized C2C12 myoblasts to model skeletal muscle differentiation.
- Examined the effects of ACE inhibition (captopril) and overexpression on myogenesis.
- Investigated the involvement of angiotensin II receptors (AT1 and AT2 antagonists: losartan and PD123319).
Main Results:
- ACE inhibition with captopril significantly increased myosin heavy chain expression and myotube hypertrophy.
- The AT2 receptor antagonist PD123319, but not the AT1 antagonist losartan, upregulated myosin heavy chain.
- Overexpression of ACE led to a downregulation of myosin heavy chain, indicating impaired myogenesis.
Conclusions:
- ACE negatively regulates myogenesis, the process of skeletal muscle formation.
- This inhibitory effect is mediated, at least partly, by angiotensin II acting through the AT2 receptor.
More Related Videos
Related Concept Videos
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...